[HTML][HTML] Blastic plasmacytoid dendritic cell neoplasm: progress in cell origin, molecular biology, diagnostic criteria and therapeutic approaches
W Cheng, T Yu, A Tang, K He Young, L Yu - Current Medical Science, 2021 - Springer
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematological malignancy
characterized by recurrent skin nodules, an aggressive clinical course with rapid …
characterized by recurrent skin nodules, an aggressive clinical course with rapid …
Tagraxofusp followed by combined azacitidine and venetoclax in blastic plasmacytoid dendritic cell neoplasm: a case report and literature review
Y Samhouri, S Ursu, N Dutton… - Journal of Oncology …, 2021 - journals.sagepub.com
Introduction Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive
hematologic malignancy that originates from plasmacytoid dendritic cells. It can involve skin …
hematologic malignancy that originates from plasmacytoid dendritic cells. It can involve skin …
Venetoclax and hypomethylating agents in older/unfit patients with blastic plasmacytoid dendritic cell neoplasm
N Gangat, M Konopleva, MM Patnaik… - American journal …, 2022 - pubmed.ncbi.nlm.nih.gov
Venetoclax and hypomethylating agents in older/unfit patients with blastic plasmacytoid
dendritic cell neoplasm Venetoclax and hypomethylating agents in older/unfit patients with …
dendritic cell neoplasm Venetoclax and hypomethylating agents in older/unfit patients with …
Targeting CD123 in BPDCN: an emerging field
AJ DiPippo, NR Wilson… - Expert review of …, 2021 - Taylor & Francis
Introduction Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive
hematologic malignancy with historically poor outcomes for patients, often refractory to …
hematologic malignancy with historically poor outcomes for patients, often refractory to …
Venetoclax combined with azacitidine in blastic plasmacytoid dendritic cell neoplasm: a case report and comprehensive review on the current and future treatment
X Wang, J Guo, Y Liu, N Zheng, S Xu, L Wu… - Frontiers in …, 2024 - frontiersin.org
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an extremely rare hematological
malignancy with a highly aggressive behavior and median survival of< 2 years. Especially …
malignancy with a highly aggressive behavior and median survival of< 2 years. Especially …
Venetoclax in relapsed/refractory blastic plasmacytoid dendritic cell neoplasm with central nervous system involvement: a case report and review of the literature
Background We describe a patient with blastic plasmacytoid dendritic cell neoplasm with
central nervous system involvement and the outcome of venetoclax use in this setting. Case …
central nervous system involvement and the outcome of venetoclax use in this setting. Case …
Blastic plasmacytoid dendritic cell neoplasm with cutaneous presentation: A case series in children
G Chan, S Akintorin, M Luu, N Harter - Pediatric Dermatology, 2021 - Wiley Online Library
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, aggressive hematologic
malignancy that can present with multiorgan involvement including the skin. While this entity …
malignancy that can present with multiorgan involvement including the skin. While this entity …